Hypertension in children with congenital adrenal hyperplasia

Nadia Maccabee-Ryaboy1, William Thomas2, Jennifer Kyllo3

  • 1University of Minnesota Masonic Children's Hospital, Minneapolis, MN, USA.

Clinical Endocrinology
|April 23, 2016
PubMed

Insights

Children with congenital adrenal hyperplasia (CAH) have increased hypertension risk, particularly those on fludrocortisone and with oversuppressed 17-OHP levels. Incidence varies by CAH subtype and sex, with salt-wasting forms showing higher rates.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health in Genetic Disorders

Background:

  • Congenital adrenal hyperplasia (CAH) presents diverse clinical phenotypes, with varying estimates of hypertension incidence.
  • Risk factors for hypertension in pediatric CAH patients remain incompletely understood.

Purpose of the Study:

  • To estimate hypertension incidence stratified by CAH subtype and sex.
  • To investigate associations between hypertension and body mass index, hydrocortisone, and fludrocortisone use.

Main Methods:

  • Longitudinal chart review of 180 pediatric CAH patients (1970-2013).
  • Hypertension defined as blood pressure ≥95th percentile on at least three occasions.
  • Analysis included CAH subtype (salt-wasting vs. simple virilizing) and medication use.

Main Results:

  • Hypertension incidence was higher in salt-wasting CAH (58%) than simple-virilizing CAH (35%).
  • Children on fludrocortisone had significantly higher hypertension rates (55% vs. 31%).
  • Oversuppression (17-OHP < 400 ng/dl) was associated with increased hypertension, especially in salt-wasting males on fludrocortisone.

Conclusions:

  • Pediatric CAH patients face elevated hypertension risk compared to the general population.
  • Fludrocortisone use and oversuppression are linked to higher hypertension incidence in CAH.
  • Hypertension risk and timing differ significantly by CAH subtype and sex.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.8K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709